AD7c-NTP

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
FOR-46FOR-46; FG-3246Phase 2 ClinicalUniversity Of California San Diego, Fortis Therapeutics IncProstatic Neoplasms, Castration-Resistant; Multiple Myeloma; Prostatic Neoplasms
Details
EnadenotucirevColoAd-1; Oncolytic Ad11/Ad3Phase 1 ClinicalAkamis Bio LtdOvarian Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colonic Neoplasms; Neoplasms, Glandular and Epithelial; Urinary Bladder Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
YS-5YS-5Phase 1 ClinicalFortis Therapeutics Inc, United States Department Of DefenseProstatic Neoplasms, Castration-Resistant; Prostatic Neoplasms
Details
  • Product Inquiry
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland